If it is said that 3D printing technology has set off a new industrial revolution, the power of design and manufacturing that was originally in the hands of a few people has been distributed to more ordinary people. Then, for the medical profession, as a 3D printing technology. The commanding height of the world - biological 3D printing technology, heralds a new medical revolution or future.

Compared with most traditional manufacturing technologies, cost is still the biggest bastion of 3D printing, and the technical advantage is not enough to offset the cost disadvantage. However, the medical field pays less attention to cost performance, and even adopts the latest technology and the best products at no cost. Moreover, the existing organ transplantation technology has long faced the dilemma of donor shortage and immune rejection. It is understood that every 1.5 hours in the world, a patient who needs an organ transplant surgery will die due to waiting. In China, 1.5 million people need organ transplants every year, and less than one percent of them are lucky to receive transplants; 10 million people each year suffer from tissue regeneration due to various diseases and accidents. This also makes the innovative application of bio 3D printing technology have great development potential and urgent clinical needs in the field of medical health.

Dr. Yuan Yuyu

In China, where the population is huge, the population is becoming more and more aging, and the medical market is very large. At the same time, the state has introduced a series of policy plans to promote the research and development of bio-3D printing technology. If it can truly realize the industrialization of bio-3D printing technology, The outlook is bright.

Developing a realistic 3D printing history opportunity

The development of global bio-3D printing technology is not long. China's research in this field is represented by universities and research institutions such as Tsinghua University and Xi'an Jiaotong University. The industry is represented by domestic bio-3D printing pioneers such as Maipu Medical, almost internationally. During the same period, research and industrialization development were carried out. Some local areas have achieved a number of important results, and they have also been initially applied in clinical practice. For example, since its establishment, Maipu Medical has successfully realized the industrialization of three types of implanted medical device products, such as artificial hard brain (ridge) membrane and tension-free urinary incontinence suspension belt, based on the biomedical 3D printing technology-based regenerative medicine platform. And obtained 3 CE registration certificates, 2 CFDA registration certificates, 1 Indian registration certificate, 1 Korean license, etc., and successfully entered the international market; among them, artificial hard brain (ridge) film - Rui film and Johnson & Johnson, Medtronic, etc. The pharmaceutical giant competes on the same stage in the world and is the first regenerative implanted device in China to go to the world's high-end market.

On July 7 this year, 3D Printing Industry, the internationally renowned 3D printing news website, published the global bio 3D printing patent statistics for 2015-2016, and Maipu Medical entered the global bio 3D printing leader list. The listed units are mainly from the United States, China, Japan and South Korea. Organovo ranks first in the list of 66 patents, followed by Wake Forest University, Royal Philips, HP, University of Texas, and General Medicine and Corning Corporation. Maipu has 14 bio 3D printing patents and is the only company in China to enter the list. To date, the number of bio 3D printing patents of its subsidiaries has exceeded 20.

In recent years, especially through the introduction of a group of “Thousand Talents” experts, China has greatly shortened the gap with developed countries in terms of technology base and talent reserve. China faces a rare historical opportunity to vigorously develop biological 3D technology and industrial development. But at the same time, we must also be aware that China's overall technical level is still far from the developed countries such as the United States, in the bio-3D, including the application of modern bio-3D printing technology and manufacturing equipment reliability, usability and industrialization. Printing and the organic intersection of materials science and life sciences, and many other theoretical and technical problems, still need to carry out systematic scientific research, especially in the field of technological innovation and application field expansion, China is still in a relatively backward position, the industrialization foundation is weak. .

China is gradually improving the quality of life and health of the people. As a country with a large population and an aging population, there is a huge demand for disease diagnosis and treatment. Whether in personalized therapeutic devices, regenerative medicine, or in pathology and pharmacology research, drug development and biopharmaceutical technology, medical imaging industries, bio 3D printing technology can play a very important role. Therefore, the research and development and industrialization of bio-3D printing technology can not only enable domestic medical equipment to reach international level, improve national health and quality of life, but also improve the level of product development in China's industrial sector, seize the commanding heights of international industry competition, and enhance the country's core competitiveness. Important opportunities and strategic choices.

YT-H706

YT-H706

YT-H706

Shenzhen Sunshine Technology Co.,Ltd , https://www.shenzhenyatwin.com